A
Andreas Kolk
Researcher at Technische Universität München
Publications - 135
Citations - 4455
Andreas Kolk is an academic researcher from Technische Universität München. The author has contributed to research in topics: Bone regeneration & Osteosynthesis. The author has an hindex of 32, co-authored 127 publications receiving 3808 citations. Previous affiliations of Andreas Kolk include Innsbruck Medical University & Ludwig Maximilian University of Munich.
Papers
More filters
Journal ArticleDOI
Current trends and future perspectives of bone substitute materials - from space holders to innovative biomaterials.
Andreas Kolk,Jörg Handschel,Wolf Drescher,Daniel Rothamel,Frank Kloss,Marco Blessmann,Max Heiland,Klaus-Dietrich Wolff,Ralf Smeets +8 more
TL;DR: An overview of the principles of bone replacement, the types of graft materials available, and future perspectives are presented and a change from a simple replacement material to an individually created composite biomaterial with osteoinductive properties to enable enhanced defect bridging is proposed.
Journal Article
Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts.
Christoph Pautke,Matthias Schieker,Thomas Tischer,Andreas Kolk,Peter Neth,Wolf Mutschler,Stefan Milz +6 more
TL;DR: It is concluded that each osteosarcoma cell line exhibits a characteristic labelling profile and thus produces a differently composed extracellular matrix, which can be used in attempts to better characterize osteosARcoma, a as well as for their diagnosis.
Journal ArticleDOI
Synthetic, pure-phase beta-tricalcium phosphate ceramic granules (Cerasorb) for bone regeneration in the reconstructive surgery of the jaws.
TL;DR: Synthetic, pure-phase beta-TCP is a suitable material for the filling of bone defects in the alveolar region because of its versatility, low complication rate and good long-term results.
Journal ArticleDOI
CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity
Melanie Straub,Enken Drecoll,Nicole Pfarr,Wilko Weichert,Rupert Langer,Alexander Hapfelmeier,Carolin Götz,Klaus-Dietrich Wolff,Andreas Kolk,Katja Specht +9 more
TL;DR: Clinically, PD-L1 tumor immunopositivity was associated with a higher risk for nodal metastasis at diagnosis, overall tumor related death und recurrence, and it is proposed to include PD- L1 copy number status in addition to protein status in screening programs for future clinical trials with immunotherapeutic strategies targeting the PD-1/PD-L 1 axis.
Journal ArticleDOI
Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study.
Sven Otto,M.H. Abu-Id,Stefano Fedele,Patrick Hans-Heinrich Warnke,Stephan T. Becker,Andreas Kolk,Thomas Mücke,Thomas Mücke,Gerson Mast,Robert Köhnke,Elias Volkmer,Florian Haasters,Olivier Lieger,Tateyuki Iizuka,Stephen Porter,Giuseppina Campisi,Giuseppe Colella,Oliver Ploder,Andreas Neff,Jörg Wiltfang,Michael Ehrenfeld,Thomas Kreusch,Klaus-Dietrich Wolff,Klaus-Dietrich Wolff,Stephen R. Stürzenbaum,Matthias Schieker,Christoph Pautke +26 more
TL;DR: The results from this study suggest that the relative frequency of osteoporosis patients on oral BPs suffering from BRONJ is higher than previously reported.